CAR T Moving Forward
Recent scientific developments, real clinical practice changes, and what is in store for EU patients
Speaker
![Elias Jabbour MD Anderson Cancer Center Aptitude Health](https://www.aptitudehealth.com/wp-content/uploads/2019/12/Elias-Jabbour-MD-Anderson-Cancer-Center-Aptitude-Health.jpg)
Elias Jabbour, MD
The University of Texas MD Anderson Cancer Center
Moderator
Chadi Nabhan, MD, MBA, FACP
Aptitude Health
Look Inside This Report
Download a sample of this report and start discovering the insights.
Topics Covered in the Report
- Integration of CAR T therapy within the community
- CAR T therapy within the setting of acute lymphoblastic leukemia (ALL), diffuse large B-cell lymphoma (DLBCL), and multiple myeloma (MM)
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- A moderated roundtable discussion focusing on CAR T-cell therapy was held on August 25, 2019, in Washington, DC, US
- Disease state and data presentations were developed in conjunction with an expert from MD Anderson Cancer Center
- The group of advisors comprised 10 community oncologists from the Northeast, US
- Data collection was accomplished through use of audience response system questioning and moderated discussion